Hence, a melanoma-specific demethylation mechanism that operates in a gene-dependent manner may compel the c-MYC, Sestrin-1, and SRPX2 transcripts to retain their introns, strongly suggesting an epigenetic control of splicing integrity. The gene discussed is MYC; the disease is melanoma.